Physician profile
Keith J Odegard
NPI 1083609614
$2,786.45
in general payments reported to CMS, 2019-2025
12 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,026 · 2020: $129 · 2021: $145 · 2022: $53.20 · 2023: $96.63 · 2024: $32.62 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $1,593.00 | 2019 | |
| Alaska Medical Technologies, LLC | $207.02 | 2025 | |
| Zimmer Biomet Holdings, INC. | $173.61 | 2020-2025 | Persona |
| 4web, INC. | $146.57 | 2019 | |
| Integra Lifesciences Corporation | $140.00 | 2019 | |
| Depuy Synthes Sales INC. | $132.47 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $106.60 | 2021-2024 | Euflexxa |
| Stryker Corporation | $105.53 | 2021 | |
| Pacira Therapeutics, INC. | $77.48 | 2019-2021 | |
| Innovation Technologies INC | $69.75 | 2023 | Irrisept |
| Medtronic USA, INC. | $17.86 | 2019 | |
| Solventum Corporation | $16.56 | 2024 | V.A.C.Instill, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Odegard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.